A study of the relationship between the proportional insulin glargine evening dose and the perioperative serum glucose values in patients with diabetes undergoing surgery.

Trial Profile

A study of the relationship between the proportional insulin glargine evening dose and the perioperative serum glucose values in patients with diabetes undergoing surgery.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2012

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2012 Actual number of patients changed from 267 to 402 as reported by ClinicalTrials.gov.
    • 22 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Oct 2008 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top